Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | LPL | P06858 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1178159 | 0.79 | PTGS1 (0.48) | TP53TSHRMAPK1ATMTDP1 | |
| SCHEMBL28973797 | 0.78 | SLC6A2 (0.61) | TAAR1ACACBCYP2A6CYP1A2CYP2D6 | |
| SCHEMBL13898915 | 0.78 | TAAR1 (0.61) | TAAR1ALDH1A1CYP1A2 | |
| SCHEMBL19546067 | 0.78 | IDO1 (0.48) | TSHRL3MBTL1ACACB | |
| SCHEMBL24603673 | 0.77 | SIGMAR1 (0.58) | TAAR1CYP2A6CYP2D6 | |
| SCHEMBL6255650 | 0.77 | SIGMAR1 (0.58) | TAAR1CYP2A6CYP2D6 | |
| SCHEMBL12528349 | 0.75 | TSHR (0.52) | TP53TSHRMAPK1ATMTDP1 | |
| SCHEMBL12342703 | 0.75 | TAAR1 (0.64) | TAAR1CYP2A6 | |
| SCHEMBL932135 | 0.75 | TAAR1 (0.64) | TAAR1CYP2A6 | |
| SCHEMBL15161169 | 0.75 | TP53 (0.42) | TP53TSHRMAPK1ATMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043636-B2 | Method for producing triarylorganoborates | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2024-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043636-B2 | Method for producing triarylorganoborates | KMO, COASY, CYP3A4 | TP53 3652/4885TSHR 3184/4885MAPK1 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.